Interpace Biosciences Inc. (IDXG)

[vintagesake]

https://www.smarteranalyst.com/2017/01/20/fridays-market-insights-interpace-diagnostics-group-inc-idxg-skyworks-solutions-inc-swks-bellerophon-therapeutics-inc-blph/



IDXG Recent Business Updates Include:

1. Evidence supporting Interpace Diagnostics’ PanDNA product presented at the American College of Gastroentrerology Annual Meeting by Dr. James Farrell, Director of the Yale Center for Pancreatic Diseases, described when and how PanDNA can help assess long term risk of pancreatic cancer in patients with pancreatic cyst lesions

2. Completed the validation and launch of two new thyroid services designed to assist physicians and clinics that prefer to have the initial Fine Needle Aspirate (FNA) biopsy assessed by an independent third party.

3. Announced New York State approval of ThyGenX™ for indeterminate thyroid nodules in October enabling us to now market both ThyGenX and ThyraMir in the state, which is known to account for approximately 5% of the 600,000 FNA biopsies in the US annually.

4. revenues up 36%(q3),up 50%(q2),

Business update courtesy of ASH111